Expertise in
36
conditions

Dr. Eric C. Leuthardt

Neurosurgery
Washington University
100 Entrance Way, 
Saint Peters, MO 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
36
conditions
Washington University
100 Entrance Way, 
Saint Peters, MO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Eric Leuthardt is a Neurosurgery provider in Saint Peters, Missouri. Dr. Leuthardt is highly rated in 36 conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Deep Brain Stimulation. Dr. Leuthardt is currently accepting new patients.

His clinical research consists of co-authoring 204 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurosurgery
Licenses
Neurological Surgery in MO
Hospital Affiliations
Barnes-Jewish West County Hospital
Barnes Jewish Hospital
Missouri Baptist Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Cox Health
  • EPO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

WASHINGTON UNIVERSITY
100 Entrance Way, Saint Peters, MO 63376

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
Enrollment Status: Recruiting
Publish Date: October 29, 2024
Intervention Type: Genetic, Device, Procedure
Study Phase: Not Applicable
A Phase I/II Study Testing the Safety, Toxicities, and Efficacy of MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas
A Phase I/II Study Testing the Safety, Toxicities, and Efficacy of MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas
Enrollment Status: Completed
Publish Date: May 29, 2025
Intervention Type: Biological, Device
Study Drug: Pembrolizumab
Study Phase: Phase 1/Phase 2
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry
Enrollment Status: Completed
Publish Date: April 24, 2025
Intervention Type: Device
A Phase I/II Dose-escalation and Dose-expansion Study of Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
A Phase I/II Dose-escalation and Dose-expansion Study of Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Completed
Publish Date: April 10, 2025
Intervention Type: Drug, Procedure, Radiation
Study Drugs: Disulfiram, Copper Gluconate, Temozolomide
Study Phase: Phase 1/Phase 2
A Pilot Study to Assess the Safety, Feasibility, and Immunogenicity of a Neoantigen-based Personalized in Patients With Newly Diagnosed, Unmethylated Glioblastoma
A Pilot Study to Assess the Safety, Feasibility, and Immunogenicity of a Neoantigen-based Personalized in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: January 10, 2025
Intervention Type: Device, Biological, Drug
Study Drugs: Personalized neoantigen DNA vaccine, Plasmid encoded IL-12
Study Phase: Phase 1
A Pilot Study of Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
A Pilot Study of Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
Enrollment Status: Terminated
Publish Date: November 01, 2024
Intervention Type: Drug, Device
Study Drugs: Doxorubicin, Etoposide
Study Phase: Phase 2
A Pilot Study to Assess the Safety, Feasibility, and Immunogenicity of a Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
A Pilot Study to Assess the Safety, Feasibility, and Immunogenicity of a Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Enrollment Status: Terminated
Publish Date: October 27, 2021
Intervention Type: Procedure, Biological
Study Phase: Phase 1
A Pilot Study of Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Doxorubicin in the Treatment of Recurrent Glioblastoma Multiforme
A Pilot Study of Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Doxorubicin in the Treatment of Recurrent Glioblastoma Multiforme
Enrollment Status: Completed
Publish Date: August 27, 2021
Intervention Type: Device, Drug, Other
Study Phase: Phase 1
A Pilot Study to Assess the Safety, Feasibility, and Preliminary Efficacy of a Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
A Pilot Study to Assess the Safety, Feasibility, and Preliminary Efficacy of a Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Terminated
Publish Date: November 17, 2017
Intervention Type: Drug, Biological
Study Phase: Phase 1
View 8 Less Clinical Trials

204 Total Publications

Sociodemographic factors predict outcomes and reveal spatial tumor patterns in glioblastoma.
Sociodemographic factors predict outcomes and reveal spatial tumor patterns in glioblastoma.
Journal: Neuro-oncology advances
Published: July 24, 2025
Similar Doctors
Expertise in
13
conditions
Dr. Jennifer Strahle
Neurosurgery
Expertise in
13
conditions
Dr. Jennifer Strahle
Neurosurgery

Washington University

100 Entrance Way, 
Saint Peters, MO 
 (0.1 miles away)
363-916-7140
Languages Spoken:
English
See accepted insurances

Jennifer Strahle is a Neurosurgery provider in Saint Peters, Missouri. Dr. Strahle is highly rated in 13 conditions, according to our data. Her top areas of expertise are Chiari Malformation Type 2, Syringomyelia, Chiari Malformation, Posterior Fossa Decompression, and Endoscopy.

Expertise in
42
conditions
Dr. Gregory Zipfel
Neurosurgery
Expertise in
42
conditions
Dr. Gregory Zipfel
Neurosurgery

Washington University

100 Entrance Way, 
Saint Peters, MO 
 (0.1 miles away)
363-916-7140
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Gregory Zipfel is a Neurosurgery provider in Saint Peters, Missouri. Dr. Zipfel is highly rated in 42 conditions, according to our data. His top areas of expertise are Subarachnoid Hemorrhage, Arteriovenous Malformation, Meningioma, Endovascular Embolization, and Thrombectomy.

Expertise in
24
conditions
Dr. Joshua W. Osbun
Neurosurgery
Expertise in
24
conditions
Dr. Joshua W. Osbun
Neurosurgery

Washington University

100 Entrance Way, 
Saint Peters, MO 
 (0.1 miles away)
363-916-7140
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joshua Osbun is a Neurosurgery provider in Saint Peters, Missouri. Dr. Osbun is highly rated in 24 conditions, according to our data. His top areas of expertise are Stroke, Brain Aneurysm, Meningioma, Thrombectomy, and Stent Placement. Dr. Osbun is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Leuthardt's expertise for a condition
ConditionClose
View All 14 Distinguished Conditions
View All 18 Advanced Conditions
View All 25 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile